Systemic barriers drive TB care delays: How colonial healthcare legacies and poverty shape diagnostic deserts

Indigenous and traditional healing systems often frame TB as a symptom of disrupted social and ecological harmony, integrating herbal remedies (e.g., *Withania somnifera* in Ayurveda, *Artemisia annua* in Chinese medicine) with community rituals that address stigma and isolation. These systems prioritize prevention through nutrition and social cohesion, yet are systematically excluded from TB control programs, which focus on biomedical testing and pharmaceuticals. In Canada, First Nations communities have successfully reduced TB rates by combining Western diagnostics with traditional healing practices, but such hybrid models remain underfunded and stigmatized by public health authorities.

TB care systems were historically shaped by colonial medical practices that segregated patients in sanitoria (e.g., India’s 19th-century 'lung hospitals') to control 'diseased natives,' embedding racial hierarchies into public health. The post-WWII shift toward vertical programs like DOTS was influenced by Cold War geopolitics, prioritizing cost-effective interventions over community-based care. Structural adjustment programs in the 1980s–90s dismantled public health infrastructure in TB-endemic countries, while privatization funneled patients toward unregulated private providers who profit from misdiagnosis and overprescription, fueling antibiotic resistance.

Cross-cultural comparisons reveal that TB thrives in settings where healthcare is commodified (e.g., India’s private sector, where 80% of TB care is out-of-pocket) versus community-centered models like Brazil’s *Farmácia Viva* (living pharmacies) or South Africa’s *Tshwane Declaration* integrating traditional healers. In Russia, TB is stigmatized as a 'prison disease,' reflecting how incarceration systems act as reservoirs for drug-resistant strains, while in Peru, indigenous Quechua communities view TB as a 'wind illness' (*enfermedad del viento*), requiring both biomedical and spiritual interventions. These diverse framings highlight the need for culturally adaptive care models.

Scientific evidence shows that TB care delays are driven by diagnostic deserts—areas where rapid molecular tests (e.g., Xpert MTB/RIF) are unavailable due to cost, supply chain failures, or weak primary care infrastructure. Studies in India and South Africa demonstrate that patients in informal settlements or rural areas often visit 3–5 providers before receiving a correct diagnosis, with delays averaging 6–12 weeks, exacerbating transmission and resistance. The Lancet’s focus on 'prompt care' ignores how poverty, stigma, and healthcare worker shortages (e.g., 1 doctor per 10,000 people in parts of sub-Saharan Africa) create structural barriers that no single test can overcome.

Artistic and spiritual traditions often depict TB as a 'consuming' illness that erodes both body and community, reflected in literature (e.g., Kafka’s *The Metamorphosis*, Camus’ *The Plague*) and visual art (e.g., Frida Kahlo’s self-portraits of physical decay). In Hindu and Buddhist traditions, TB is linked to past-life karma or imbalances in *doshas* (Ayurveda), while in African diasporic traditions, it may be framed as a 'curse' or 'spiritual attack' requiring cleansing rituals. These framings, though often dismissed as superstition, can serve as metaphors for societal neglect, as seen in South Africa’s *struggle narratives* where TB symbolized apartheid’s violence.

Future TB control models must integrate predictive analytics (e.g., AI-driven risk mapping for diagnostic deserts) with community-based care networks to address structural inequities. Scenario planning suggests that without addressing poverty and housing insecurity, even 90-90-90 targets (90% diagnosed, 90% treated, 90% cured) will fail to reduce transmission, as seen in the Philippines where urban slums see TB rates 5x higher than national averages. Decolonizing TB care requires shifting from 'compliance' to 'co-production,' where patients and communities design interventions aligned with their cultural and material realities.

Marginalized groups—migrant laborers, incarcerated populations, indigenous peoples, and women in patriarchal societies—face compounded barriers to TB care, including legal exclusion (e.g., undocumented migrants), gendered stigma (e.g., women blamed for 'spreading' TB), and environmental racism (e.g., TB hotspots in mining communities). In Canada, Inuit communities report TB rates 300x the national average due to overcrowded housing and food insecurity, yet their knowledge of traditional foods (e.g., seal oil) as immune boosters is ignored in public health campaigns. The Lancet’s framing centers 'patients' as abstract individuals, erasing the power imbalances that shape their access to care.